Trials / Conditions / Drug Metabolism, Poor, CYP2C19-RELATED
Drug Metabolism, Poor, CYP2C19-RELATED
4 registered clinical trials studyying Drug Metabolism, Poor, CYP2C19-RELATED — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: NCT06322238 | Mayo Clinic | Phase 2 |
| Completed | Pharmacogenetic Testing Among Home Health Patients NCT02378220 | Genelex Corporation | N/A |
| Completed | Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM NCT02428660 | Genelex Corporation | N/A |
| Completed | YouScript IMPACT Registry NCT02191358 | Genelex Corporation | — |